These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4370585)

  • 1. [Use of aminoglutethimide in the treatment of Cushing's syndrome].
    Jacobelli A; Borgia MC; Borgia C; Sellini M
    Minerva Med; 1974 Jan; 65(3):156-62. PubMed ID: 4370585
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
    Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged remission in Cushing's syndrome following treatment with ortho-para-dichlordiphenyldichlorethane].
    Kirkegaard C; Kolendorf K
    Ugeskr Laeger; 1974 Jun; 136(25):1389-91. PubMed ID: 4366485
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aminoglutethimide in the treatment of Cushing's syndrome (observation of 10 cases)].
    Kasperlik-Załuska A; Migdalska B
    Pol Tyg Lek; 1983 Mar; 38(11):333-6. PubMed ID: 6634478
    [No Abstract]   [Full Text] [Related]  

  • 5. Values for urinary free cortisol during treatment with amino-glutethimide for Cushing's syndrome.
    Schmitt KW; Juselius R; Hanlon J; Steed D
    Clin Chem; 1973 Sep; 19(9):1067-8. PubMed ID: 4744809
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of cyproheptadine in the treatment of Cushing's disease].
    Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
    Clin Ter; 1979 Feb; 88(4):345-54. PubMed ID: 222530
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Hunter PR; Ross W; Hall R; Cook DB
    Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1225. PubMed ID: 4375290
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synthetic cortisol antagonists in the treatment of adrenal gland hypercortisolism. Results of 8 years of use].
    Bricaire H; Luton JP
    Therapie; 1974; 29(5):645-58. PubMed ID: 4462221
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Givens JR; Camacho A; Patterson P
    Metabolism; 1970 Oct; 19(10):818-30. PubMed ID: 4918596
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
    Thorén M; Adamson U; Sjöberg HE
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of aminoglutethimide in a case of Cushing's syndrome due to ectopic ACTH production].
    Neri V; Schieppati G; Rondena M; Cozzi C
    Clin Ter; 1977 Oct; 83(2):163-73. PubMed ID: 201424
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of Cushing's disease treated by aminoglutethimide].
    Thevenet M; Lumbroso P; Netter A
    Ann Endocrinol (Paris); 1968; 29(3):346-50. PubMed ID: 4326387
    [No Abstract]   [Full Text] [Related]  

  • 13. [Agents inhibiting steroid biosynthesis--aminoglutethimide and o,p'-DDD].
    Aida M; Miura K
    Nihon Rinsho; 1974 Nov; 32(11):3257-61. PubMed ID: 4375206
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of aminoglutethimide on cortisol secretion in Cushing's disease].
    Boyer J; Valette A; Latrabe J; Codaccioni JL
    Ann Endocrinol (Paris); 1973; 34(5):519-26. PubMed ID: 4368116
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of responsiveness to L-dopa in Cushing's disease.
    Krieger DT
    J Clin Endocrinol Metab; 1973 Feb; 36(2):277-84. PubMed ID: 4345691
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-invasive therapy of Cushing's syndrome].
    Miura K
    Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1627-32. PubMed ID: 7798761
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical usefulness of pharmacological treatment of Cushing's syndrome].
    Saito J; Nishikawa T
    Nihon Rinsho; 1994 Mar; 52(3):793-6. PubMed ID: 8164384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis.
    Carey RM; Orth DN; Hartmann WH
    J Clin Endocrinol Metab; 1973 Mar; 36(3):482-7. PubMed ID: 4119547
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing's syndrome with dual pituitary-adrenal control.
    Choi Y; Werk EE; Sholiton LJ
    Arch Intern Med; 1970 Jun; 125(6):1045-9. PubMed ID: 4378134
    [No Abstract]   [Full Text] [Related]  

  • 20. Capillaritis (purpura simplex) associated with use of aminoglutethimide in Cushing's syndrome.
    Stratakis CA; Chrousos GP
    Am J Hosp Pharm; 1994 Oct; 51(20):2589-91. PubMed ID: 7847422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.